The consequences of cyberattacks for all
We all know that cyberattacks are bad for our industry. They can cause disruption to our IT systems, delay processing orders and make distributing products ten times harder. Yet many companies will brush aside this risk, assuming that robust firewalls and standard protocols will protect their years of hard work.
Until it reaches one of the world’s leading MedTech firms and the risk returns to the spotlight.
When Boston Scientific experienced a significant cyber incident earlier this year, operations grounded to a halt with no immediate timeline for recovery. Months later, while their core systems gradually returned to normal, the fallout extended beyond just troubleshooting.
Disruptions like these hit production pipelines, complicate hospital distribution, cause missed quarterly forecasts, and can easily wipe market value off company shares within a matter of days.
For industry giants with deep cash reserves and buffer inventory, a blackout is expensive and frustrating, but survivable. But for the more early-stage MedTech startups, this exact same attack can be fatal.
When revenue depends on single product launches or initial rollouts, this downtime can destroy a company's valuation and break down years of trust.
Building for the future requires a clear focus in all areas. As digital health platforms and cloud-integrated manufacturing continue to expand, cybersecurity can no longer be just an afterthought. As taught by recent events, in the world of modern MedTech, cyber resilience is as critical to patient safety as the innovation itself.
Pavanpreet Gohani - Biomedical Editor
Sources https://pharmaphorum.com/news/cyberattack-boston-scientific-causes-global-ops-disruption
https://news.bostonscientific.com/update-on-recent-cybersecurity-incident
https://www.wsj.com/business/boston-scientific-wont-meet-guidance-due-to-cyberattack-feb29ee1